{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:09:23Z","timestamp":1789646963541,"version":"4.0.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>High-density lipoprotein cholesterol (HDL-C), non-HDL-C, and the ratio of non-HDL-C to HDL-C (NHHR) are closely correlated with multiple metabolic diseases. This study aims to dissect their associations and differences in relation to new-onset MASLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected from research subjects at the Health Management Center of the Second Affiliated Hospital of Dalian Medical University between 2014 and 2023. Participants were stratified by quartiles of HDL-C, non-HDL-C, and NHHR. Kaplan\u2013Meier analysis, Cox proportional hazards models, restricted cubic splines (RCS), sensitivity analyses, and receiver operating characteristic (ROC) curves were employed to evaluate associations between NHHR, non-HDL-C, HDL-C, and new-onset MASLD and compare predictive performance across lipid parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 36,897 participants (mean age 42.1 years; 56.5% female) were followed for a mean of 3.19 years, with 20.3% developing new-onset MASLD. Cox regression showed that compared to the Q1 group, the Q4 group of NHHR and non-HDL-C had a 134% (HR=2.34, 95% CI: 2.13\u20132.56) and 22% (HR=1.22, 95% CI: 1.13\u20131.31) higher risk of MASLD, respectively, while HDL-C was associated with a 45% lower risk (HR=0.55, 95% CI: 0.50\u20130.60). RCS analysis demonstrated nonlinear relationships for NHHR (threshold = 2.54) and HDL-C (threshold = 1.31 mmol\/L), whereas non-HDL-C displayed a linear, positive association with MASLD risk. Stratified analyses revealed that elevated non-HDL-C levels conferred higher MASLD risk in men, whereas females, younger adults, and individuals with lower cardiometabolic burden (BMI &amp;lt;24 kg\/m\u00b2, nonhypertensive, and nonhyperuricemic status) showed steeper increases in MASLD risk with rising NHHR quartiles. ROC analysis indicated NHHR was superior to other lipid parameters in predicting MASLD risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Decreases in HDL-C levels and increases in non-HDL-C and NHHR levels may increase the risk of MASLD. The NHHR can be used as a new index that is stronger than other lipoproteins for the prediction of MASLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1585811","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:15:43Z","timestamp":1750220143000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Associations between high-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and their ratio with metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12967-023-04291-4","article-title":"Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study","volume":"21","author":"Lee","year":"2023","journal-title":"J Transl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12967-023-04047-0","article-title":"Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis","volume":"21","author":"Lu","year":"2023","journal-title":"J Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319894114","article-title":"Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease","volume":"27","author":"Feng","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.0912","article-title":"Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations","volume":"7","author":"Liu","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.903481","article-title":"U-shaped relationship of non-HDL cholesterol with all-cause and cardiovascular mortality in men without statin therapy","volume":"9","author":"Zeng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02143-8","article-title":"The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with type 2 diabetes mellitus: recent findings from NHANES 2007-2018","volume":"23","author":"Tan","year":"2024","journal-title":"Lipids Health disease"},{"key":"B13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12944-024-02292-w","article-title":"The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is associated with thyroid hormones and thyroid hormone sensitivity indices: a cross-sectional study","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12944-024-02309-4","article-title":"Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study","volume":"23","author":"Liu","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1038\/s41598-024-56276-y","article-title":"The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and prevalence of periodontitis among US adults: a cross-sectional NHANES study","volume":"14","author":"Hou","year":"2024","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12944-024-02171-4","article-title":"The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia","volume":"23","author":"Wang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and Malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","first-page":"24847","DOI":"10.1038\/s41598-024-76002-y","article-title":"The association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in US adults: a cross-sectional study","volume":"14","author":"Huang","year":"2024","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1457589","article-title":"Elevated non-HDL-C to HDL-C ratio as a marker for NAFLD and liver fibrosis risk: a cross-sectional analysis","volume":"15","author":"Xuan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1477820","article-title":"The correlation between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with non-alcoholic fatty liver disease: an analysis of the population-based NHANES (2017-2018)","volume":"11","author":"Yang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11909\/j.issn.1671-5411.2019.03.014","article-title":"2018 Chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of Chinese guidelines for prevention and treatment of hypertension","volume":"16","author":"Joint","year":"2019","journal-title":"J geriatric cardiol: JGC"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2019.1660048","article-title":"Epidemiology and prevalence of hyperuricemia among men and women in Chinese rural population: The Henan Rural Cohort Study","volume":"30","author":"Dong","year":"2020","journal-title":"Mod Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2022.09.006","article-title":"A mechanism-based operational definition and classification of hypercholesterolemia","volume":"16","author":"Civeira","year":"2022","journal-title":"J Clin Lipidol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12944-018-0848-8","article-title":"Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study","volume":"17","author":"Wang","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B26","article-title":"Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study","volume":"13","author":"Gao","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101185","article-title":"Lipid metabolism in MASLD and MASH: From mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14856","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study","volume":"35","author":"Sinn","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jacl.2017.02.001","article-title":"Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia","volume":"11","author":"Amor","year":"2017","journal-title":"J Clin Lipidol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1590\/1677-5449.180109","article-title":"HDL-C and non-HDL-C levels are associated with anthropometric and biochemical parameters","volume":"18","author":"Barbalho","year":"2019","journal-title":"J Vasc Bras"},{"key":"B34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12944-017-0621-4","article-title":"Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2020.09.013","article-title":"Serum non-high-density lipoprotein cholesterol level is increased in Chinese patients with nonalcoholic fatty liver disease","volume":"19","author":"Shao","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32519-X","article-title":"Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium","volume":"394","author":"Brunner","year":"2019","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1065750","article-title":"The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population","volume":"10","author":"Huang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.99.3.354","article-title":"Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women","volume":"99","author":"Koh","year":"1999","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","article-title":"Interaction between high-density lipoproteins and inflammation: Function matters more than concentration","volume":"159","author":"Nazir","year":"2020","journal-title":"Adv Drug Delivery Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034393","article-title":"U-shaped relationship of high-density lipoprotein cholesterol and incidence of total, ischemic and hemorrhagic stroke: A prospective cohort study","volume":"53","author":"Li","year":"2022","journal-title":"Stroke"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-018-9186-0","article-title":"Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease","volume":"15","author":"Rao","year":"2018","journal-title":"Clin Proteomics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.01.029","article-title":"Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps","volume":"282","author":"Santos","year":"2019","journal-title":"Atherosclerosis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajg.2014.05.002","article-title":"Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt","volume":"15","author":"Alkassabany","year":"2014","journal-title":"Arab J Gastroenterol"},{"key":"B44","article-title":"Association between high density lipoprotein and nonalcoholic fatty liver disease: a cross-sectional study in Japanese population","volume":"9","author":"Liang","year":"2021","journal-title":"J Clin Lab Management"},{"key":"B45","doi-asserted-by":"publisher","first-page":"18547","DOI":"10.1038\/s41598-024-69411-6","article-title":"Baseline and change in serum lipid and uric acid level over time and incident of nonalcoholic fatty liver disease (NAFLD) in Chinese adults","volume":"14","author":"Huang","year":"2024","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0209","article-title":"Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register","volume":"34","author":"Eliasson","year":"2011","journal-title":"Diabetes Care"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2174\/1570161116666180711121949","article-title":"Menopause and non-alcoholic fatty liver disease: A review focusing on therapeutic perspectives","volume":"17","author":"Venetsanaki","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1557751","article-title":"Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Yang","year":"2025","journal-title":"Front Nutr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.12.016","article-title":"Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma","volume":"11","author":"Luedde","year":"2007","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12933-019-0954-6","article-title":"Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1\/2 pathway","volume":"18","author":"Wu","year":"2019","journal-title":"Cardiovasc Diabetol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585811\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:15:46Z","timestamp":1750220146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585811\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":51,"alternative-id":["10.3389\/fendo.2025.1585811"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1585811","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1585811"}}